Skip to navigation Skip to content



Information from Medtronic about possible battery issues in Synchromed® drug pumps

August 15, 2011

In July, Medtronic provided physicians with new information about possible reduced battery performance in a small percentage of the SynchroMed® drug pumps used to deliver intrathecal baclofen, a medication used to treat severe spasticity. A battery with reduced performance may need to be replaced sooner than expected. In addition, the reduced performance may cause the drug flow rate to be reset to a very low level. In the event of reduced battery performance, a person would experience a significant increase in spasticity or and perhaps some withdrawal symptoms as the supply of medication is decreased. Medtronic is NOT recommending pump replacement because the risk of this change in battery performance is very low, and the surgery poses its own risks. The pump’s alarm system will sound if there is a problem. Read here for more information on the Medtronic Web site or call Medtronic Patient Services toll free at 1 (800) 510-6735.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.